SC
PRCT icon

Steven Cohen’s Procept Biorobotics PRCT Stock Holding History

Steven Cohen’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,400
Closed -$285K – 4465
2026
Q1 		$285K Hold
11,400
– – ﹤0.01% 3384
2025
Q4 		$359K Buy
+11,400
New +$378K ﹤0.01% 3396
2024
Q1 		– Sell
-100,000
Closed -$4.19M – 2527
2023
Q4 		$4.19M Buy
+100,000
New +$3.41M 0.01% 993

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Steven Cohen's PRCT Position: Q2 2026 in Review

Steven Cohen sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 1,128,543 shares — an estimated $28.2M sold.

Steven Cohen first reported a position in PRCT in Q3 2021 and held it in 4 quarters. The position peaked at $28.2M in Q1 2026. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Steven Cohen reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 1,128,543 Procept Biorobotics shares in Q2 2026, an estimated $28.2M.
  • Steven Cohen first reported a position in Procept Biorobotics in Q3 2021 and held it in 4 quarters.
  • Steven Cohen's Procept Biorobotics position peaked at $28.2M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.